821 related articles for article (PubMed ID: 6845551)
1. [Oral contraceptives: update].
Fugère P
Union Med Can; 1983 Feb; 112(2):109-12. PubMed ID: 6845551
[No Abstract] [Full Text] [Related]
2. Oral contraceptives and the risk of cardiovascular disease.
Med Lett Drugs Ther; 1983 Jul; 25(640):69-70. PubMed ID: 6865850
[TBL] [Abstract][Full Text] [Related]
3. Oral contraceptives and cardiovascular disease (first of two parts).
Stadel BV
N Engl J Med; 1981 Sep; 305(11):612-8. PubMed ID: 7022208
[No Abstract] [Full Text] [Related]
4. [Oral estroprogestational contraception in 1987 and its complications].
Renaud R; Lellouche D
Rev Prat; 1987 Sep; 37(38):2267-76. PubMed ID: 3659793
[No Abstract] [Full Text] [Related]
5. [Oral contraceptives: 30 vs 20 micrograms of ethinyl estradiol (EE)].
Urdinola J
Adv Contracept; 1994 Jul; 10 Suppl 1():41-9. PubMed ID: 7839871
[No Abstract] [Full Text] [Related]
6. [Current aspects of the oral hormonal contraception].
Avramova V
Akush Ginekol (Sofiia); 2008; 47 Suppl 2():49-59. PubMed ID: 19504710
[No Abstract] [Full Text] [Related]
7. Genital cancer and oral contraceptives. The good news!
Skouby SO
Eur J Contracept Reprod Health Care; 2008 Dec; 13(4):327-9. PubMed ID: 19117249
[No Abstract] [Full Text] [Related]
8. Growth of leiomyomata with estrogen--progestogen therapy.
John AH; Martin R
J Reprod Med; 1971 Feb; 6(2):56-8. PubMed ID: 5115282
[No Abstract] [Full Text] [Related]
9. Oral contraceptives and endometrial and cervical cancer.
Moghissi KS
J Toxicol Environ Health; 1977 Sep; 3(1-2):243-65. PubMed ID: 336901
[No Abstract] [Full Text] [Related]
10. [Changes in the endometrium from the use of hormonal preparations and hormonal contraceptives].
Jellinek G
Arkh Patol; 1978; 40(11):36-45. PubMed ID: 736819
[TBL] [Abstract][Full Text] [Related]
11. Oral oestrogen-progestagen contraceptives, menopausal treatment, and cancer.
Shapiro S
Lancet Oncol; 2005 Oct; 6(10):736; author reply 737. PubMed ID: 16198976
[No Abstract] [Full Text] [Related]
12. [Hormonal contraceptives].
Martínez-Manautou J; Giner J
Gac Med Mex; 1970 Oct; 100(10):993-1026. PubMed ID: 4943137
[No Abstract] [Full Text] [Related]
13. Complications of the new contraceptive preparations.
Clinch J
Ir Med J; 1978 Oct; 71(15):513-4. PubMed ID: 711437
[No Abstract] [Full Text] [Related]
14. [A further case of hepatocytic adenoma following oestrogen-progestogen treatment. Review of the published literature (author's transl)].
Grandjean JP; Vignal J; Seffert P; Mestrallet G; Beurlet J; Quiviger P
Ann Chir; 1979 May; 33(5):361-70. PubMed ID: 389138
[No Abstract] [Full Text] [Related]
15. [Hormonal contraceptives, peripheral venous insufficiency and the use of a phlebodynamic agent].
Cervantes A; Gorodovsky J; Peña A; Campos J
Ginecol Obstet Mex; 1976 Aug; 40(238):113-6. PubMed ID: 786800
[No Abstract] [Full Text] [Related]
16. Cardiovascular disease and steroid hormone contraception. Report of a WHO Scientific Group.
World Health Organ Tech Rep Ser; 1998; 877():i-vii, 1-89. PubMed ID: 9615606
[TBL] [Abstract][Full Text] [Related]
17. [Contraceptives. Side effects and risks].
García-Conti F
Rev Colomb Obstet Ginecol; 1971; 22(6):393-407. PubMed ID: 4947668
[No Abstract] [Full Text] [Related]
18. Hormonal replacement therapy--cardiovascular disease.
Silfverstolpe G; Crona N
Acta Obstet Gynecol Scand Suppl; 1986; 134():93-5. PubMed ID: 3028030
[No Abstract] [Full Text] [Related]
19. [Reflexions on a new generation of oral contraceptives].
Gaspard U
J Gynecol Obstet Biol Reprod (Paris); 1985; 14(1):85-92. PubMed ID: 4008893
[TBL] [Abstract][Full Text] [Related]
20. [Oral contraceptives and oral candidiasis].
Krekeler G; Ochs G; Haderthauer W
Fortschr Med; 1981 Feb; 99(7):230-2. PubMed ID: 7216106
[No Abstract] [Full Text] [Related]
[Next] [New Search]
